Analyst Price Targets — TMDX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 5, 2026 11:35 am | — | Robert W. Baird | $122.00 | $80.75 | TheFly | TransMedics price target raised to $122 from $120 at Baird |
| August 5, 2026 11:19 am | — | Canaccord Genuity | $95.00 | $80.75 | TheFly | TransMedics price target lowered to $95 from $124 at Canaccord |
| August 5, 2026 11:10 am | — | Stifel Nicolaus | $65.00 | $80.75 | TheFly | TransMedics price target lowered to $65 from $80 at Stifel |
| August 3, 2026 11:12 am | Mike Matson | Needham | $106.00 | $76.51 | StreetInsider | TransMedics Group (TMDX) PT Lowered to $106 at Needham |
| July 28, 2026 10:44 am | — | UBS | $80.00 | $74.28 | TheFly | TransMedics initiated with a Neutral at UBS |
| July 6, 2026 12:48 pm | Daniel Markowitz | Evercore ISI | $90.00 | $70.77 | TheFly | TransMedics price target lowered to $90 from $100 at Evercore ISI |
| June 18, 2026 10:36 am | — | Stifel Nicolaus | $80.00 | $73.22 | TheFly | TransMedics price target raised to $80 from $75 at Stifel |
| May 26, 2026 10:50 am | Thomas Stephan | Stifel Nicolaus | $75.00 | $68.94 | TheFly | TransMedics price target lowered to $75 from $85 at Stifel |
| May 6, 2026 1:42 pm | — | Needham | $142.00 | $73.84 | TheFly | TransMedics price target lowered to $142 from $174 at Needham |
| May 6, 2026 11:46 am | William Plovanic | Canaccord Genuity | $124.00 | $94.93 | TheFly | TransMedics price target lowered to $124 from $152 at Canaccord |
Latest News for TMDX
TransMedics' rapid revenue growth and cheaper valuation face rising margin pressure as heavy investment raises execution risks.
TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock?
NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of TransMedics Group, Inc. (NASDAQ: TMDX).
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX
NEW YORK, Aug. 31, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of TransMedics Group, Inc. (NASDAQ: TMDX). If you currently own shares of TransMedics Group stock, please visit the firm's website at https://rosenlegal.com/cases/transmedics-group-inc/join for more information.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for TMDX.
U.S. House Trading
No House trades found for TMDX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.